To the Editor In the wake of the recently published ω-3 polyunsaturated fatty acids multisite trial (NEURAPRO) by McGorry et al1 in JAMA Psychiatry (n = 304), the 3 largest studies of preventive interventions in individuals at ultrahigh risk (UHR) for psychosis have turned out to be negative (Morrison et al,2 n = 288; McFarlane et al,3 n = 292), suggesting that it may not currently be possible to prevent psychosis. However, the actual risk for psychosis in these interventional studies was found to be extremely low, even in the control group (11.2% in the McGorry et al1 study at 1 year, 9% at 2 years in the Morrison et al2 study, and 2.3% at 2 years in the McFarlane et al3 study), implying that these negative findings are likely to be secondary to small statistical power.
Fusar-Poli P. Negative Psychosis Prevention Trials. JAMA Psychiatry. 2017;74(6):651. doi:10.1001/jamapsychiatry.2017.0185
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.